Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of head and neck: A phase III study of high dose radiation therapy with or without cetuximab
-
- J. A. Bonner
- University of Alabama, Birmingham, AL; University of Wisconsin, Madison, WI; Vall D'Hebron University Hospital, Barcelona, Spain; ImClone Systems, Somerville, NJ; University of Virginia, Charlottesville, VA; University of Colorado, Aurora, CO; Sutter Cancer Center, Sacramento, CA; UT MD Anderson Cancer Center, Houston, TX
-
- P. M. Harari
- University of Alabama, Birmingham, AL; University of Wisconsin, Madison, WI; Vall D'Hebron University Hospital, Barcelona, Spain; ImClone Systems, Somerville, NJ; University of Virginia, Charlottesville, VA; University of Colorado, Aurora, CO; Sutter Cancer Center, Sacramento, CA; UT MD Anderson Cancer Center, Houston, TX
-
- J. Giralt
- University of Alabama, Birmingham, AL; University of Wisconsin, Madison, WI; Vall D'Hebron University Hospital, Barcelona, Spain; ImClone Systems, Somerville, NJ; University of Virginia, Charlottesville, VA; University of Colorado, Aurora, CO; Sutter Cancer Center, Sacramento, CA; UT MD Anderson Cancer Center, Houston, TX
-
- N. Azarnia
- University of Alabama, Birmingham, AL; University of Wisconsin, Madison, WI; Vall D'Hebron University Hospital, Barcelona, Spain; ImClone Systems, Somerville, NJ; University of Virginia, Charlottesville, VA; University of Colorado, Aurora, CO; Sutter Cancer Center, Sacramento, CA; UT MD Anderson Cancer Center, Houston, TX
-
- R. B. Cohen
- University of Alabama, Birmingham, AL; University of Wisconsin, Madison, WI; Vall D'Hebron University Hospital, Barcelona, Spain; ImClone Systems, Somerville, NJ; University of Virginia, Charlottesville, VA; University of Colorado, Aurora, CO; Sutter Cancer Center, Sacramento, CA; UT MD Anderson Cancer Center, Houston, TX
-
- D. Raben
- University of Alabama, Birmingham, AL; University of Wisconsin, Madison, WI; Vall D'Hebron University Hospital, Barcelona, Spain; ImClone Systems, Somerville, NJ; University of Virginia, Charlottesville, VA; University of Colorado, Aurora, CO; Sutter Cancer Center, Sacramento, CA; UT MD Anderson Cancer Center, Houston, TX
-
- C. Jones
- University of Alabama, Birmingham, AL; University of Wisconsin, Madison, WI; Vall D'Hebron University Hospital, Barcelona, Spain; ImClone Systems, Somerville, NJ; University of Virginia, Charlottesville, VA; University of Colorado, Aurora, CO; Sutter Cancer Center, Sacramento, CA; UT MD Anderson Cancer Center, Houston, TX
-
- M. S. Kies
- University of Alabama, Birmingham, AL; University of Wisconsin, Madison, WI; Vall D'Hebron University Hospital, Barcelona, Spain; ImClone Systems, Somerville, NJ; University of Virginia, Charlottesville, VA; University of Colorado, Aurora, CO; Sutter Cancer Center, Sacramento, CA; UT MD Anderson Cancer Center, Houston, TX
-
- J. Baselga
- University of Alabama, Birmingham, AL; University of Wisconsin, Madison, WI; Vall D'Hebron University Hospital, Barcelona, Spain; ImClone Systems, Somerville, NJ; University of Virginia, Charlottesville, VA; University of Colorado, Aurora, CO; Sutter Cancer Center, Sacramento, CA; UT MD Anderson Cancer Center, Houston, TX
-
- K. K. Ang
- University of Alabama, Birmingham, AL; University of Wisconsin, Madison, WI; Vall D'Hebron University Hospital, Barcelona, Spain; ImClone Systems, Somerville, NJ; University of Virginia, Charlottesville, VA; University of Colorado, Aurora, CO; Sutter Cancer Center, Sacramento, CA; UT MD Anderson Cancer Center, Houston, TX
収録刊行物
-
- Journal of Clinical Oncology
-
Journal of Clinical Oncology 22 (14_suppl), 5507-5507, 2004-07-15
American Society of Clinical Oncology (ASCO)